Billing Codes
CPT 81414: Cardiac Ion Channelopathy CNV Panel
CPT-81470-XLID-MULTIGENE-GENOMIC-SEQUENCING-PANELCPT 81470: Multigene Genomic Sequencing Panel for X‑Linked Intellectual Disability
CPT-81473-MOLECULAR-PATHOLOGY-TEST-81473CPT 81473: Molecular Pathology Test
CPT-81418-PHARMACOGENOMIC-MULTIGENE-DRUG-METABOLISM-PANELCPT 81418: Pharmacogenomic Multigene Drug-Metabolism Panel
CPT-81449-TUMOR-RNA-SEQUENCING-PANEL-5-50-GENESCPT 81449: Tumor RNA Sequencing Panel, 5–50 Genes
CPT-81475-MOLECULAR-DIAGNOSTIC-VARIANT-ANALYSISCPT 81475: Molecular Diagnostic Variant Analysis
CPT-81403-TIER-2-LEVEL-4-MOLECULAR-PATHOLOGY-TECHNICALCPT 81403: Tier 2 Level 4 Molecular Pathology, Laboratory Technical Component
CPT-81445-SOLID-TUMOR-GENOMIC-SEQUENCE-PANEL-5-50-GENESCPT 81445: Solid Tumor Genomic Sequence Panel, 5–50 Genes
CPT-81477-MOLECULAR-DIAGNOSTIC-MULTI-GENE-PANEL-SEQUENCINGCPT 81477: Molecular Diagnostic Multi-Gene Panel Sequencing
CPT-81400-MOLECULAR-PATHOLOGY-TECHNICAL-LAB-PROCEDURECPT 81400: Technical Molecular Pathology Laboratory Procedure
Showing 1–10 of 78
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.